MARIA RAMIREZ: Open Payments
NPI 1801540562 · WILSON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 35 payments from 15 companies in 2025. Trend: 2023 $953 · 2024 $756 · 2025 $695
Food & beverage: $695
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $195 |
| ABBVIE INC. | 10 | $153 |
| Lilly USA, LLC | 3 | $57 |
| Corcept Therapeutics | 3 | $46 |
| Novo Nordisk Inc | 3 | $45 |
| Amgen Inc. | 2 | $32 |
| Viatris Specialty LLC | 2 | $29 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| AGEPHA Pharma FZ LLC | 1 | $17 |
Products named: AIRSUPRA, UBRELVY, Korlym, MOUNJARO, FARXIGA, Wegovy, YUPELRI, TRELEGY ELLIPTA.
Industry payments across NC — which companies pay providers there.
